Medical Castration With LHRH Agonists: 25 Years Later With Major Benefits Achieved on Survival in Prostate Cancer
Author:
Publisher
Wiley
Subject
Urology,Endocrinology,Reproductive Medicine,Endocrinology, Diabetes and Metabolism
Reference57 articles.
1. An oncology perspective on the benefits and cost of combined androgen blockade in advanced prostate cancer;Aprikian;Can J Urol,2003
2. Potent inhibitory activity of [D-Leu6, des-Gly-NH210] ethylamide on LH/hCG and PRL testicular receptor levels in the rat;Auclair;Endocrinology,1977a
3. Inhibition of testicular luteinizing receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist of human chorionic gonadotropin;Auclair;Biochem Biophys Res Commun,1977b
4. Maximum androgen-blockade with medical or surgical castration in advanced prostate cancer: a meta-analysis of nine published randomized controlled trials and 4128 patients using Flutamide;Bennett;Prostate Cancer Prost Dis,1999
5. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin;Bolla;N Engl J Med,1997
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review;Medical Oncology;2023-05-10
2. Preclinical models of prostate cancer — modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo;Nature Reviews Urology;2023-02-14
3. Conventional androgen deprivation therapy is associated with an increased risk of fracture in advanced prostate cancer, a nationwide population-based study;PLOS ONE;2023-01-04
4. Testosterone castration levels in patients with prostate cancer: Is there a difference between GnRH agonist and GnRH antagonist? Primary results of an open-label randomized control study;Investigative and Clinical Urology;2023
5. Lokal İleri Evre Prostat Kanserinde Maksimal Androjen Blokaj Tedavisinin Hematolojik, Biyokimyasal Ve Kemik Yoğunluğu Parametreleri Üzerine Etkileri;Acta Medica Alanya;2018-10-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3